The Conversation (0)
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847. There is no cost or financial obligation to you.
Infrastructure and Energy Alternatives, Inc. (Nasdaq - IEA)
Under the terms of the agreement and plan of merger, IEA will be acquired by MasTec (NYSE – MTZ) in a cash-and-stock transaction. IEA stockholders will receive $14.00 per share, comprised of $10.50 per share in cash and 0.0483 of a MasTec share, with a value of $3.50 per share, based on MasTec's closing share price on July 22, 2022. The investigation concerns whether the IEA Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether MasTec is paying too little for the Company.
Additional information can be found at https://www.brodskysmith.com/cases/infrastructure-energy-alternatives-inc-nasdaq-iea/ .
Sharps Compliance Corp. (Nasdaq - SMED)
Under the terms of the agreement, Sharps will be acquired by an affiliate of Aurora Capital Partners ("Aurora"). Aurora will commence an all-cash tender offer to acquire all of the issued and outstanding shares of Sharps for $8.75 per share. The investigation concerns whether the Sharps Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Aurora is paying too little for the Company. For example, the deal consideration is below the 52-week high of $10.47 for the Company's shares.
Additional information can be found at https://www.brodskysmith.com/cases/sharps-compliance-corp-nasdaq-smed/ .
AutoWeb, Inc. (Nasdaq - AUTO)
Under the terms of the agreement, AutoWeb will be acquired by a subsidiary (the "Purchaser") of One Planet Group, LLC ("One Planet Group"), under which the Purchaser will pay a cash purchase price of $0.39 per share of AutoWeb. The investigation concerns whether the AutoWeb Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Purchaser is paying too little for the Company.
Additional information can be found at https://www.brodskysmith.com/cases/autoweb-inc-nasdaq-auto/ .
Zymergen Inc. (Nasdaq - ZY)
Under the terms of the agreement, Zymergen will be acquired by Ginkgo Bioworks (NYSE - DNA). Zymergen stockholders will receive a fixed exchange ratio of 0.9179 Ginkgo shares for each Zymergen share in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization. The investigation concerns whether the Zymergen Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Gingko Bioworks is paying too little for the Company.
Additional information can be found at https://www.brodskysmith.com/cases/zymergen-inc-nasdaq-zy/ .
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
